Department of Orthopaedics, Xi'an Jiaotong University, Xi'an, 710000, China.
Department of Orthopaedics, Xi'an Central Hospital, Xi'an, 710000, China.
Sci Rep. 2021 Sep 9;11(1):17971. doi: 10.1038/s41598-021-97474-2.
Rheumatoid arthritis (RA) is an autoimmune disease associated with advanced joint dysfunction. Madhuca indica J. F. Gmel, from the family Sapotaceae, is an Indian medicinal plant reported to have an array of pharmacological properties. The aim of present investigation was to determine the anti-arthritic potential of an isolated phytoconstituent from methanolic leaf extract of Madhuca indica (MI-ALC) against FCA-induced experimental arthritis. Polyarthritis was induced in female rats (strain: Wistar) via an intradermal injection of FCA (0.1 mL) into the tail. Polyarthritis developed after 32 days of FCA administration. Then rats were treated orally with an isolated phytoconstituent from MI-ALC at doses of 5, 10, and 20 mg/kg. Findings suggested that High-Performance Thin-Layer Chromatography, Fourier-Transform Infrared Spectroscopy, and Liquid Chromatography-Mass Spectrometry spectral analyses of the phytoconstituent isolated from MI-ALC confirmed the structure as 3,5,7,3',4'-Pentahydroxy flavone (i.e., QTN). Treatment with QTN (10 and 20 mg/kg) showed significant (p < 0.05) inhibition of increased joint diameter, paw volume, paw withdrawal threshold, and latency. The elevated synovial oxidative stress (Superoxide dismutase, reduced glutathione, and malondialdehyde) and protein levels of Tumor necrosis factor-α (TNF-α) and Interleukin (ILs) were markedly (p < 0.05) reduced by QTN. It also effectively (p < 0.05) ameliorated cyclooxygenase-2 (COX-2), Nuclear factor of kappa light polypeptide gene enhancer in B cells (NF-kβ) and its inhibitor-α (Ikβα), and ATP-activated P2 purinergic receptors (P2X7) protein expressions as determined by western blot analysis. In conclusion, QTN ameliorates FCA-induced hyperalgesia through modulation of elevated inflammatory release (NF-kβ, Ikβα, P2X7, and COX-2), oxido-nitrosative stress, and pro-inflammatory cytokines (ILs and TNF-α) in experimental rats.
类风湿性关节炎(RA)是一种与关节功能障碍有关的自身免疫性疾病。Madhu-ca indica J. F. Gmel,属于金虎尾科,是一种被报道具有多种药理学特性的印度药用植物。本研究的目的是确定从 Madhuca indica(MI-ALC)甲醇叶提取物中分离出的一种植物成分对弗氏完全佐剂(FCA)诱导的实验性关节炎的抗关节炎潜力。通过向尾巴皮内注射 FCA(0.1 mL),在雌性大鼠(品系:Wistar)中诱导多发性关节炎。在 FCA 给药 32 天后,多发性关节炎发展。然后,大鼠口服给予 MI-ALC 分离的植物成分,剂量为 5、10 和 20 mg/kg。结果表明,从 MI-ALC 中分离出的植物成分的高效薄层色谱、傅里叶变换红外光谱和液相色谱-质谱光谱分析证实其结构为 3,5,7,3',4'-五羟基黄酮(即 QTN)。QTN(10 和 20 mg/kg)治疗可显著(p<0.05)抑制关节直径、爪体积、爪退缩阈值和潜伏期的增加。QTN 显著(p<0.05)降低了升高的滑膜氧化应激(超氧化物歧化酶、还原型谷胱甘肽和丙二醛)和肿瘤坏死因子-α(TNF-α)和白细胞介素(ILs)的蛋白水平。它还通过 Western blot 分析有效地(p<0.05)改善了环氧化酶-2(COX-2)、核因子κ轻链增强子 B 细胞(NF-κβ)及其抑制剂-α(Ikβα)和三磷酸腺苷激活的 P2 嘌呤能受体(P2X7)的蛋白表达。总之,QTN 通过调节实验大鼠升高的炎症释放(NF-κβ、Ikβα、P2X7 和 COX-2)、氧化应激和促炎细胞因子(ILs 和 TNF-α)来改善 FCA 诱导的痛觉过敏。